Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Change in Inventory (2016 - 2019)

Aptevo Therapeutics' Change in Inventory history spans 5 years, with the latest figure at -$1.3 million for Q4 2019.

  • For Q4 2019, Change in Inventory changed N/A year-over-year to -$1.3 million; the TTM value through Dec 2019 reached $4.4 million, changed N/A, while the annual FY2019 figure was $4.4 million, 475.17% up from the prior year.
  • Change in Inventory for Q4 2019 was -$1.3 million at Aptevo Therapeutics, down from $515000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.9 million in Q3 2018 and bottomed at -$8.6 million in Q3 2016.
  • The 5-year median for Change in Inventory is $257000.0 (2018), against an average of -$226000.0.
  • The largest annual shift saw Change in Inventory crashed 827.55% in 2016 before it skyrocketed 1453.6% in 2018.
  • A 5-year view of Change in Inventory shows it stood at -$1.4 million in 2015, then tumbled by 253.51% to -$4.9 million in 2016, then soared by 95.76% to -$209000.0 in 2017, then surged by 1507.18% to $2.9 million in 2018, then plummeted by 145.66% to -$1.3 million in 2019.
  • Per Business Quant, the three most recent readings for APVO's Change in Inventory are -$1.3 million (Q4 2019), $515000.0 (Q3 2019), and $2.6 million (Q2 2019).